טוען...
The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction
BACKGROUND/AIMS: It is unknown whether different β-blockers (BBs) have variable effects on long-term survival of patients with heart failure with reduced ejection fraction (HFrEF). This study compares the effects of two BBs, carvedilol and bisoprolol, on survival in patients with HFrEF. METHODS: The...
שמור ב:
| הוצא לאור ב: | Korean J Intern Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Korean Association of Internal Medicine
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6718755/ https://ncbi.nlm.nih.gov/pubmed/30317846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2018.009 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|